DIA
ABBV icon

Denver Investment Advisors’s AbbVie ABBV Stock Holding History

Denver Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$9.03M Sell
95,360
-2,116
-2% -$232K 0.48% 88
2017
Q4 		$9.43M Buy
97,476
+433
+0.4% +$40.8K 0.47% 93
2017
Q3 		$8.62M Sell
97,043
-1,809
-2% -$138K 0.42% 101
2017
Q2 		$7.17M Sell
98,852
-1,085
-1% -$72.9K 0.32% 110
2017
Q1 		$6.51M Sell
99,937
-7,912
-7% -$497K 0.29% 114
2016
Q4 		$7.03M Buy
107,849
+13,878
+15% +$847K 0.3% 115
2016
Q3 		$5.93M Buy
93,971
+95
+0.1% +$6.15K 0.26% 114
2016
Q2 		$5.81M Sell
93,876
-518
-0.5% -$31.6K 0.26% 118
2016
Q1 		$5.39M Buy
94,394
+455
+0.5% +$25.4K 0.24% 129
2015
Q4 		$5.57M Buy
93,939
+3,134
+3% +$181K 0.25% 123
2015
Q3 		$4.94M Sell
90,805
-4,760
-5% -$310K 0.22% 126
2015
Q2 		$6.42M Sell
95,565
-6,676
-7% -$436K 0.24% 115
2015
Q1 		$5.99M Sell
102,241
-94,458
-48% -$5.71M 0.2% 132
2014
Q4 		$12.9M Sell
196,699
-24,466
-11% -$1.54M 0.41% 76
2014
Q3 		$12.8M Sell
221,165
-2,146
-1% -$119K 0.42% 72
2014
Q2 		$12.6M Sell
223,311
-215
-0.1% -$11.3K 0.38% 71
2014
Q1 		$11.5M Sell
223,526
-103,329
-32% -$5.22M 0.34% 96
2013
Q4 		$17.3K Buy
326,855
+96,776
+42% +$4.76M 0.49% 59
2013
Q3 		$10.3M Buy
230,079
+2,912
+1% +$129K 0.22% 134
2013
Q2 		$9.39M Buy
+227,167
New +$9.94M 0.22% 142

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Denver Investment Advisors's ABBV Position: Q1 2018 in Review

Denver Investment Advisors reduced its AbbVie (ABBV) stake by 2.2% in Q1 2018, selling an estimated $232K and leaving 95,360 shares worth $9.03M. The position accounts for 0.48% of the portfolio, ranked #88.

Denver Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 20 quarters since. The position peaked at $12.9M in Q4 2014. 2,016 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

  • Denver Investment Advisors held 95,360 shares of AbbVie worth $9.03M as of Q1 2018.
  • Denver Investment Advisors sold 2,116 AbbVie shares in Q1 2018, an estimated $232K.
  • AbbVie made up 0.48% of Denver Investment Advisors's portfolio in Q1 2018, its #88 holding.
  • Denver Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 20 quarters since.
  • Denver Investment Advisors's AbbVie position peaked at $12.9M in Q4 2014.
  • 2,016 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.